The Fanconi anemia/BRCA pathway: A coordinator of cross-link repair

Experimental Cell Research

Volumn 312, Issue 14, 2006, Pages 2647-2653

  Mirchandani, Kanchan D ^a   D'Andrea, Alan D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DNA cross links; Fanconi anemia; Mitomycin C; Translesion DNA synthesis

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; APHIDICOLIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CISPLATIN; CROSS LINKING REAGENT; FANCONI ANEMIA PROTEIN; HYDROXYUREA; PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

CANCER RISK; CANCER SUSCEPTIBILITY; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA STRAND; EXCISION REPAIR; FANCONI ANEMIA; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; INHERITANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 33746758821     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.06.014     Document Type: Review

References (50)

1. Kennedy R.D., and D'Andrea A.D. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev. 19 (2005) 2925-2940
2. D'Andrea A.D., and Grompe M. The Fanconi anaemia/BRCA pathway. Nat. Rev., Cancer 3 (2003) 23-34
3. Poll E.H., Arwert F., Joenje H., and Wanamarta A.H. Differential sensitivity of Fanconi anaemia lymphocytes to the clastogenic action of cis-diamminedichloroplatinum (II) and trans-diamminedichloroplatinum (II). Hum. Genet. 71 (1985) 206-210
4. German J., Schonberg S., Caskie S., Warburton D., Falk C., and Ray J.H. A test for Fanconi's anemia. Blood 69 (1987) 1637-1641
5. Auerbach A.D. A test for Fanconi's anemia. Blood 72 (1988) 366-367
6. Niedernhofer L.J., Lalai A.S., and Hoeijmakers J.H. Fanconi anemia (cross)linked to DNA repair. Cell 123 (2005) 1191-1198
7. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., and Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 (2003) 165-170
8. Gurtan A.M., Stuckert P., and D'Andrea A.D. The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly. J. Biol. Chem. 281 (2006) 10896-10905
9. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
10. Wang X., Andreassen P.R., and D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24 (2004) 5850-5862
11. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., and D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
12. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M.A., Pals G., Arwert F., Mathew C.G., Zdzienicka M.Z., Hiom K., De Winter J.P., and Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37 (2005) 934-935
13. Bridge W.L., Vandenberg C.J., Franklin R.J., and Hiom K. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37 (2005) 953-957
14. Dronkert M.L., and Kanaar R. Repair of DNA interstrand cross-links. Mutat. Res. 486 (2001) 217-247
15. Rothfuss A., and Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 24 (2004) 123-134
16. Niedernhofer L.J., Odijk H., Budzowska M., van Drunen E., Maas A., Theil A.F., de Wit J., Jaspers N.G., Beverloo H.B., Hoeijmakers J.H., and Kanaar R. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol. Cell. Biol. 24 (2004) 5776-5787
17. Lambert M.W., Tsongalis G.J., Lambert W.C., Hang B., and Parrish D.D. Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B. Mutat. Res. 273 (1992) 57-71
18. Kalb R., Duerr M., Wagner M., Herterich S., Gross M., Digweed M., Joenje H., Hoehn H., and Schindler D. Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat. Res. 161 (2004) 318-325
19. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1110-1115
20. Yamamoto K., Ishiai M., Matsushita N., Arakawa H., Lamerdin J.E., Buerstedde J.M., Tanimoto M., Harada M., Thompson L.H., and Takata M. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23 (2003) 5421-5430
21. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., and Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell 15 (2004) 607-620
22. Davies A.A., Masson J.Y., McIlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., and West S.C. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7 (2001) 273-282
23. Lomonosov M., Anand S., Sangrithi M., Davies R., and Venkitaraman A.R. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes Dev. 17 (2003) 3017-3022
24. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., and Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 (2002) 1121-1126
25. Ohashi A., Zdzienicka M.Z., Chen J., and Couch F.J. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J. Biol. Chem. 280 (2005) 14877-14883
26. Godthelp B.C., Wiegant W.W., Waisfisz Q., Medhurst A.L., Arwert F., Joenje H., and Zdzienicka M.Z. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat. Res. 594 (2006) 39-48
27. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., and Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 (2005) 958-963
28. Mosedale G., Niedzwiedz W., Alpi A., Perrina F., Pereira-Leal J.B., Johnson M., Langevin F., Pace P., and Patel K.J. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12 (2005) 763-771
29. Sobeck A., Stone S., Costanzo V., de Graaf B., Reuter T., de Winter J., Wallisch M., Akkari Y., Olson S., Wang W., Joenje H., Christian J.L., Lupardus P.J., Cimprich K.A., Gautier J., and Hoatlin M.E. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol. Cell. Biol. 26 (2006) 425-437
30. Kannouche P.L., Wing J., and Lehmann A.R. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14 (2004) 491-500
31. Howlett N.G., Taniguchi T., Durkin S.G., D'Andrea A.D., and Glover T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 14 (2005) 693-701
32. Matsushita N., Kitao H., Ishiai M., Nagashima N., Hirano S., Okawa K., Ohta T., Yu D.S., McHugh P.J., Hickson I.D., Venkitaraman A.R., Kurumizaka H., and Takata M. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19 (2005) 841-847
33. Hussain S., Wilson J.B., Blom E., Thompson L.H., Sung P., Gordon S.M., Kupfer G.M., Joenje H., Mathew C.G., and Jones N.J. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair (Amst.) (2006) 629-640
34. Papadopoulo D., Guillouf C., Porfirio B., and Moustacchi E. Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. Prog. Clin. Biol. Res. 340A (1990) 241-248
35. Papadopoulo D., Guillouf C., Mohrenweiser H., and Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 8383-8387
36. Friedberg E.C., Wagner R., and Radman M. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 296 (2002) 1627-1630
37. Bienko M., Green C.M., Crosetto N., Rudolf F., Zapart G., Coull B., Kannouche P., Wider G., Peter M., Lehmann A.R., Hofmann K., and Dikic I. Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science 310 (2005) 1821-1824
38. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., and Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419 (2002) 135-141
39. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., and Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 (2004) 1241-1248
40. Park W.H., Margossian S., Horwitz A.A., Simons A.M., D'Andrea A.D., and Parvin J.D. Direct DNA binding activity of the Fanconi anemia D2 protein. J. Biol. Chem. 280 (2005) 23593-23598
41. Nijman S.M., Huang T.T., Dirac A.M., Brummelkamp T.R., Kerkhoven R.M., D'Andrea A.D., and Bernards R. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17 (2005) 331-339
42. Huang T.T., Nijman S.M., Mirchandani K.D., Galardy P.J., Cohn M.A., Haas W., Gygi S.P., Ploegh H.L., Bernards R., and D'Andrea A.D. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8 (2006) 341-347
43. Lieber M.R., Ma Y., Pannicke U., and Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev., Mol. Cell Biol. 4 (2003) 712-720
44. Pannicke U., Ma Y., Hopfner K.P., Niewolik D., Lieber M.R., and Schwarz K. Functional and biochemical dissection of the structure-specific nuclease ARTEMIS. EMBO J. 23 (2004) 1987-1997
45. Houghtaling S., Newell A., Akkari Y., Taniguchi T., Olson S., and Grompe M. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Hum. Mol. Genet. 14 (2005) 3027-3033
46. Escarceller M., Buchwald M., Singleton B.K., Jeggo P.A., Jackson S.P., Moustacchi E., and Papadopoulo D. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J. Mol. Biol. 279 (1998) 375-385
47. Smith J., Andrau J.C., Kallenbach S., Laquerbe A., Doyen N., and Papadopoulo D. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J. Mol. Biol. 281 (1998) 815-825
48. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., and D'Andrea A.D. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 (2002) 459-472
49. Taniguchi T., and D'Andrea A.D. The molecular pathogenesis of Fanconi anemia: recent progress. Blood (2006)
50. Chirnomas D., Taniguchi T., de la Vega M., Vaidya A.P., Vasserman M., Hartman A.R., Kennedy R., Foster R., Mahoney J., Seiden M.V., and D'Andrea A.D. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther. 5 (2006) 952-961